Tissue collected earlier in the pathogenic process may demonstrate increased binding of Smad3 to the ITGB6 promoter, however obtaining human lung tissue from IPF patients with newly diagnosed IPF is problematic. The gene discussed is ITGB6; the disease is idiopathic pulmonary fibrosis.